Quick Answer
BioScience Health Innovations, Inc. reported Stockholders Equity of $1.48 million for the year ending 2025.
- BioScience Health Innovations, Inc. showed an increase of +76.9% in Stockholders Equity from 2024 to 2025.
- This data is from BioScience Health Innovations, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2019 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2019: $1.9 thousand | Q1 2020: -$26.00 | Q2 2020: -$15.7 thousand | Q4 2020: $7.2 thousand | Q1 2021: -$5.4 thousand | Q2 2021: -$8.6 thousand | Q3 2021: -$12.8 thousand | Q4 2021: $73.1 thousand | Q1 2022: $55.6 thousand | Q1 2022: -$944.00 | Q2 2022: $7.7 thousand | Q2 2022: -$2.8 thousand | Q3 2022: $14.4 thousand | Q3 2022: -$37.5 thousand | Q4 2022: $25.5 thousand | Q1 2023: $5.5 thousand | Q1 2023: -$89.0 thousand | Q2 2023: -$54.3 thousand | Q3 2023: $8.6 thousand | Q1 2024: $114.9 thousand | Q2 2024: $189.1 thousand | Q3 2024: $370.3 thousand | Q1 2025: $1.26 million | Q2 2025: $1.72 million | Q3 2025: $1.71 million.
- Historical annual values: Fiscal year 2025: $1.48 million | Fiscal year 2024: $835.2 thousand | Fiscal year 2023: -$6.8 thousand | Fiscal year 2022: -$17.2 thousand | Fiscal year 2022: $14.4 thousand | Fiscal year 2021: -$1.0 thousand | Fiscal year 2021: -$12.8 thousand | Fiscal year 2020: $12.8 thousand | Fiscal year 2019: $1.9 thousand | Fiscal year 2019: $0.00.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: